Canadian research group inks MRI R&D deal with GE

By staff writers

September 23, 2015 -- A research center operated by the Nova Scotia Health Authority is collaborating with the Canadian division of GE Healthcare in a partnership designed to develop new MRI software for diagnosing and treating diseases of the brain, liver, and prostate.

The health authority's Biomedical Translational Imaging Centre (BIOTIC) said the deal with GE Healthcare Canada builds on the acquisition of a GE 3-tesla MRI scanner by QEII Health Sciences Centre in Halifax, Nova Scotia. The goal of the partnership is to validate and commercialize software tools that could be added as features on GE MRI scanners.

The software includes technology for providing automated software tools for presurgical functional brain mapping, liver disease, and prostate cancer, the companies said.

Copyright © 2015

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking